News dal mondo
17
Mar
EMA Management Board: highlights of March 2026 meeting
Board adopts Agency’s 2025 annual report and notes electronic product information implementation roadmap EMA annual report 2025 Preparations for implementation of the new EU pharmaceutical legislation Electronic product information implementation roadmap EMA reports on stakeholder engagement activities 2024-2025 Monitoring EMA’s independence policies Impact of war in the Middle East Executive Director vacancy notice Clinical trials in the EU
Board adopts Agency’s 2025 annual report and notes electronic product information implementation roadmap
27
Apr
US QMM: Participants scored well on commitment to quality, lower on advanced manufacturing
Pharmaceutical companies participating in the US Food and Drug Administration (FDA) Quality Maturity...
23
Top Drugs at Risk of Supply Shortages
Nearly half of 100 vulnerable medicines have at least one key starting material sourced exclusively...
Regulatory considerations for pharmaceutical excipient selection
The article discusses the role and importance of excipients in medicines, focusing on regulatory aspects...
21
TGA clarifies therapeutic goods are unaffected by chemical production and import ban
TGA has clarified the impact of Australia’s industrial chemicals standards on medicines, medical...
le ultime news
20 Mar
Iran, blocco Hormuz su produzione farmaci: 'se dura ci sarà impatto tra 6 mesi'
19 Mar
Nuove norme UE sui farmaci: più incentivi all’innovazione e controllo della disponibilità
As Iran war squeezes Middle East drug shipments, experts warn of longer-term effects on US manufacturing, generics
Farmalabor: investiti 8,5 milioni in un progetto per le malattie rare
17 Mar
13 Mar
Dal China all’India-shoring, il rischio di una nuova dipendenza
11 Mar
EU Finalizes Pharma Reform Package, Clarifies New Rules On Modular Market Protection
PFAS restriction proposal: ECHA’s Socio-Economic Analysis Committee agrees its draft opinion
<<<3 4 5>>>
